Blog: Nestle receives green light on Pfizer deal

Michelle Russell | 6 November 2012

Swiss food group Nestle today (6 November) received approval from the Chinese Ministry of Commerce for its US$11.85bn deal to acquire Pfizer's infant nutrition business.

The approval brings Nestle another step closer to completing the acquisition, which was announced in April this year, enabling the world's largest infant nutrition group to extend its lead in this fast-growing category.

Pfizer Nutrition operates in more than 60 countries globally and 85% of sales are generated in emerging markets, meaning the acquisition effectively fills in the blanks on the map for Nestle. It will provide the company with increased scale in a high-growth, high-margin, category in fast-growing developing markets, CEO Paul Bulcke told investors as it emerged as victor of competitive auction process.

Nestle beat companies including Danone and Mead Johnson to seal the agreement. The next hurdle, however, is to receive approval from anti-trust bodies in several countries in order to fully complete the acquisition.


BLOG

Kellogg takeover chatter cools

Market speculation over a possible takeover of Kellogg surfaced this week, with the snacks-to-cereal maker linked to both Kraft Heinz and Coca Cola Co....

BLOG

More understanding needed of GMOs among consumers

The introduction of legislation requiring the labelling of GMOs in the US has gathered widespread public support....

BLOG

UK report examines "risks and challenges" to food system from climate change

The impact on the global food system is one of "six key priority areas" highlighted in the UK Climate Change Risk Assessment 2017 report, which sets out "the most urgent risks and opportunities" arisi...

BLOG

Brexit – the just-food confidence survey

Following last month's referendum in the UK on the country's membership of the European Union, the repercussions from the decision to leave have been felt far and wide....

just-food homepage



Forgot your password?